Understanding and addressing factors in Alzheimer's disease and related dementias
Core B: Clinical Core
This study is looking for a diverse group of people to help us learn more about Alzheimer's and related memory issues, especially focusing on those who might be at risk, so we can find new ways to understand and treat these conditions.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10883726 on NIH RePORTER |
What this research studies
This research focuses on recruiting a diverse group of participants to study Alzheimer's disease and related dementias. By gathering detailed clinical and biomarker information, the project aims to identify non-amyloid factors that contribute to brain dysfunction and neurodegeneration. The study will expand its participant base to include individuals at risk for cognitive decline, particularly from underrepresented communities. Participants will be involved in various clinical trials and observational studies to enhance understanding and treatment of these conditions.
Who could benefit from this research
Good fit: Ideal candidates include individuals at risk for or showing early signs of cognitive decline, particularly from diverse backgrounds.
Not a fit: Patients with advanced Alzheimer's disease or those not showing any signs of cognitive decline may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown success in similar approaches, particularly in enhancing understanding of Alzheimer's disease through diverse participant recruitment.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Hampstead, Benjamin Michael — University of Michigan at Ann Arbor
- Study coordinator: Hampstead, Benjamin Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.